ELTX Archived Articles
Elicio Therapeutics (ELTX): A Promising Pipeline of Lymph Node-Targeted Immunotherapies
Published on March 17, 2025
Elicio Therapeutics (NASDAQ:ELTX): Pioneering Lymph Node-Targeted Immunotherapies for Cancer Patients
Published on November 30, 2024